Zoonotic & Vector-Borne Diseases

In response to the growing outbreak, and the escalating need for a vaccine that can be used in infants, those who are immunocompromised, and other populations in whom currently available vaccines are not to be administered, the NIAID has entered a vaccine manufactured by Bavarian Nordic into Phase I trials.

After failed requests for funding and warnings of the inevitable, the Florida Department of Health is investigating what could be the first cases of active Zika Transmission in the United States.

Leptospirosis is an important zoonotic bacterial disease of worldwide public health importance. It affects humans, domestic animals, and wildlife and is caused by different Leptospira serovars.

A recent report describes a case of infectious aortitis and resultant mycotic abdominal aneurysm that arose as rare complications of exposure to Pasteurella multocida from a cat bite in a male patient.

Researchers in Guadeloupe, the French territory in the southern Caribbean Sea, have reported, for the first time, the presence of Zika infection in the genital tract of a woman with the virus.

Researchers from the University of California-San Francisco (UCSF) have provided a roadmap for how the Zika virus travels from the blood of an infected pregnant woman to her fetus, providing new clues to the process by which the disease leads to birth defects.

As a second case of non–travel-related Zika infection comes to light in Florida, researchers from Brazil discover another mosquito that they believe may be spreading the virus.

The Centers for Disease Control and Prevention (CDC) announced that it will be granting a total of $60 million, in addition to previously granted funds, to states, cities, and territories, to protect Americans from the virus.

CDC Public Health Response Director Warns Lack of Funds Hampers Protection Efforts

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention (CDC) explains the precautions that are already underway to protect the American public from the transference of the Zika virus.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention (CDC) shares the main point to keep in mind about the Zika virus.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention (CDC) shares which infectious disease he feels needs greater attention.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention (CDC) shares how the CDC is working to protect Americans from travel-associated Zika infections and touches on preparations for the Olympics.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention (CDC) explains how the CDC responds to outbreaks.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response, at the Centers for Disease Control and Prevention explains what they learned from handling the response to the Ebola outbreak in 2014-2015.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention (CDC) explains how the CDC is partnering with global organizations to proactively act on the Zika virus.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention (CDC) explains how the CDC is working to protect Americans from the Zika virus.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention (CDC) explains what the CDC learned from responding to the Ebola outbreak and how this has impacted the response to the Zika virus.

The Centers for Disease Control and Prevention (CDC) is currently working with local health officials to investigate what seems to be the first case of locally-acquired Zika in the United States.

Despite one reported death from West Nile Virus in November 2015, Louisiana health officials report a decline in the occurrence of the mosquito-borne illness.

Which came first: high Zika viral load or a diminished immune system? This is a question that epidemiologists and medical experts from the Centers for Disease Control and Prevention are pondering in regards to the recent case of Zika identified in Salt Lake City, Utah that may have resulted in the individual's death.

That may be the “$64,000 Question” facing clinicians in South America and the Caribbean, where 3 viruses linked with the Aedes aegypti mosquito have caused concurrent epidemics, resulting in confusion as efforts are made to diagnose and treat them.

With more humans encroaching the forest habitats, there are more opportunities for the acquisition of pathogens from their natural hosts.

Abdulla Al-Khan, MD, director of the Division of Maternal-Fetal Medicine and Surgery at Hackensack University Medical Center, discusses how long after exposure to Zika that a woman should wait before undergoing IVF therapy.

On the heels of new data suggesting the Zika epidemic will last for another 3 years, a new case reveals there may be a new mode of zika transmission.

Congress failed to reach a decision on Zika funding today as a new study reveals that the epidemic is expected to last well into 2019.

With the 2016 Rio Olympic Games less than one month away, the Centers for Disease Control and Prevention (CDC) released a statement summarizing their assessment of the risk of Zika importation by those returning from the summer Games.

Abdulla Al-Khan, MD, director of the Division of Maternal-Fetal Medicine and Surgery at Hackensack University Medical Center, describes his learnings from delivering a baby with Zika-related microcephaly.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, explains how the Zika virus affects fetuses of infected pregnant women.

A molecule in green tea, known as epigallocatechin (EGCG), blocks the entry of a Brazilian strain of Zika virus into host cells, and may hold potential benefit for prevention of Zika virus infections, a new study has found.